These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9044324)

  • 1. Outcome of renal replacement therapy in autosomal dominant polycystic kidney disease.
    Pirson Y; Christophe JL; Goffin E
    Nephrol Dial Transplant; 1996; 11 Suppl 6():24-8. PubMed ID: 9044324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control study. The U.C.L. Collaborative Group.
    Christophe JL; van Ypersele de Strihou C; Pirson Y
    Nephrol Dial Transplant; 1996 Jul; 11(7):1271-6. PubMed ID: 8672022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry.
    Spithoven EM; Kramer A; Meijer E; Orskov B; Wanner C; Abad JM; Aresté N; de la Torre RA; Caskey F; Couchoud C; Finne P; Heaf J; Hoitsma A; de Meester J; Pascual J; Postorino M; Ravani P; Zurriaga O; Jager KJ; Gansevoort RT; ; ;
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4(Suppl 4):iv15-25. PubMed ID: 25165182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease.
    Spithoven EM; Kramer A; Meijer E; Orskov B; Wanner C; Caskey F; Collart F; Finne P; Fogarty DG; Groothoff JW; Hoitsma A; Nogier MB; Postorino M; Ravani P; Zurriaga O; Jager KJ; Gansevoort RT; ; ; ; ;
    Kidney Int; 2014 Dec; 86(6):1244-52. PubMed ID: 24827775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renal replacement therapy in adult dominant polycystic kidney disease--multicentre study].
    Lezaić V; Ostrić V; Popović G; Vukoje M; Dragolić B; Kostić N; Stojanović M; Labudović M; Mandić M; Djordjević V; Baković J
    Srp Arh Celok Lek; 2008 Dec; 136 Suppl 4():287-93. PubMed ID: 20804097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010.
    Reule S; Sexton DJ; Solid CA; Chen SC; Collins AJ; Foley RN
    Am J Kidney Dis; 2014 Oct; 64(4):592-9. PubMed ID: 25134777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal dominant policystic kidney disease, more than a renal disease.
    Torra R
    Minerva Endocrinol; 2014 Jun; 39(2):79-87. PubMed ID: 24736482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of patients in England and Wales with autosomal dominant polycystic kidney disease and end-stage renal failure.
    Shaw C; Simms RJ; Pitcher D; Sandford R
    Nephrol Dial Transplant; 2014 Oct; 29(10):1910-8. PubMed ID: 24737444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two cases of autosomal dominant polycystic kidney disease treated with hemodialysis associated with polycystic liver complications related to the cause of death].
    Saima S; Suzuki Y; Yoshimoto K; Nakamura Y; Munakata A
    Nihon Jinzo Gakkai Shi; 1996 Jun; 38(6):278-84. PubMed ID: 8752971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of ESRD in patients with autosomal dominant polycystic kidney disease.
    Alam A; Perrone RD
    Adv Chronic Kidney Dis; 2010 Mar; 17(2):164-72. PubMed ID: 20219619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal transplantation in Autosomal Dominant Polycystic Kidney Disease (ADPKD)].
    Perico N; Cortinovis M; Remuzzi G
    G Ital Nefrol; 2016; 33(5):. PubMed ID: 27796021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality.
    Perrone RD; Ruthazer R; Terrin NC
    Am J Kidney Dis; 2001 Oct; 38(4):777-84. PubMed ID: 11576881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unilateral nephrectomy versus renal arterial embolization and technique survival in peritoneal dialysis patients with autosomal dominant polycystic kidney disease.
    Pierre M; Moreau K; Braconnier A; Kanagaratnam L; Lessore De Sainte Foy C; Sigogne M; Béchade C; Petrache A; Verger C; Frimat L; Duval-Sabatier A; Caillard S; Halin P; Touam M; Issad B; Vrtovsnik F; Petitpierre F; Lobbedez T; Touré F
    Nephrol Dial Transplant; 2020 Feb; 35(2):320-327. PubMed ID: 31747008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is CAPD a viable option among ADPKD with end stage renal disease population in India? Its outcomes and economics.
    Kaul A; Dharshan R; Bhadhuaria D; Prasad N; Gupta A; Sharma RK
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):906-11. PubMed ID: 26354561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease.
    Li L; Szeto CC; Kwan BC; Chow KM; Leung CB; Kam-Tao Li P
    Am J Kidney Dis; 2011 Jun; 57(6):903-7. PubMed ID: 21458901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of autosomal dominant polycystic kidney disease patients on peritoneal dialysis: a national retrospective study based on two French registries (the French Language Peritoneal Dialysis Registry and the French Renal Epidemiology and Information Network).
    Sigogne M; Kanagaratnam L; Dupont V; Couchoud C; Verger C; Maheut H; Hazzan M; Halimi JM; Barbe C; Canivet E; Petrache A; Dramé M; Rieu P; Touré F
    Nephrol Dial Transplant; 2018 Nov; 33(11):2020-2026. PubMed ID: 29361078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAPD in patients with autosomal dominant polycystic kidney disease.
    Hadimeri H; Johansson AC; Haraldsson B; Nyberg G
    Perit Dial Int; 1998; 18(4):429-32. PubMed ID: 10505567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretransplant Nephrectomy for Large Polycystic Kidneys in ADPKD (Autosomal Dominant Polycystic Kidney Disease) Patients: Is Peritoneal Dialysis Recovery Possible after Surgery?
    Ietto G; Raveglia V; Zani E; Iovino D; Parise C; Soldini G; Delfrate NW; Latham L; Saredi G; Benedetti F; Tozzi M; Carcano G
    Biomed Res Int; 2019; 2019():7343182. PubMed ID: 31019972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic kidney disease: etiology, pathogenesis, and treatment.
    Martinez JR; Grantham JJ
    Dis Mon; 1995 Nov; 41(11):693-765. PubMed ID: 7587886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal dominant polycystic kidney disease--the patient on renal replacement therapy.
    Zeier M; Jones E; Ritz E
    Nephrol Dial Transplant; 1996; 11 Suppl 6():18-20. PubMed ID: 9044322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.